CJC-1295 (No DAC) / IPAMORELIN
This product is a research blend combining CJC-1295 (No DAC) and Ipamorelin, providing 10 mg of each peptide in one vial. CJC-1295 is a GHRH analog that stimulates the release of growth hormone via pituitary GHRH receptors, while Ipamorelin is a selective ghrelin
(GHS-R) agonist that triggers growth hormone release through a complementary pathway. Together, this dual-peptide formulation allows researchers to investigate synergistic effects on pulsatile GH secretion, pituitary signaling, and downstream IGF-1 production.
Description
● Contents: 20 MG total (10 MG CJC-1295 No DAC + 10 MG Ipamorelin)
● Appearance: White lyophilized powder
● Formula: CJC-1295 No DAC – C_152H_252N_44O_42; Ipamorelin – C_38H_49N_9O_5
● M.W.: ~3367.9 g/mol (CJC-1295); ~711.9 g/mol (Ipamorelin)
● CAS #: CJC-1295 – 863288-34-0; Ipamorelin – 170851-70-4
● Storage: Store at −20 °C; once reconstituted, aliquot and freeze to avoid degradation
● Intended Use: For laboratory research use only
Note: Not for human or veterinary use. For in-vitro research only.
Additional information
| Size | 10mg total (5mg/5mg), 20mg total (10mg/10mg) |
|---|